OVERVIEW
PT-141 (Bremelanotide) is a synthetic research peptide utilized in preclinical laboratory models to investigate melanocortin receptor signaling and related neuropeptide pathways.
What is it?
PT-141 is a synthetic melanocortin peptide developed for investigational and in vitro research use. It is structurally derived from alpha-melanocyte-stimulating hormone (α-MSH) and is designed to selectively interact with melanocortin receptor pathways rather than vascular smooth muscle mechanisms.
In preclinical and experimental research settings, PT-141 has been examined for its influence on central nervous system signaling associated with motivation, arousal, and behavioral response pathways. Its receptor-level activity has made it a compound of interest in laboratory models exploring neuroendocrine communication and melanocortin system function.
MECHANISM OF INTEREST
|
Pathway |
Description |
|
Melanocortin Signaling |
Studied for interaction with melanocortin receptor pathways in preclinical models. |
|
Neuropeptide Signaling |
Evaluated in research settings for central neuropeptide signaling mechanisms. |
|
Receptor Binding |
Used in laboratory studies examining receptor–ligand interaction dynamics. |
KEY RESEARCH APPLICATIONS
- Melanocortin receptor signaling research
- Neuropeptide and CNS pathway modeling
- Receptor binding and signaling studies
SPECIFICATIONS
|
Attribute |
Detail |
|
Purity |
≥ 98% (HPLC) |
|
Form |
Lyophilized peptide |
|
Appearance |
White to off-white powder |
|
Molecular Weight |
~1025 Da |
|
Container |
Sterile glass vial |
HANDLING & STORAGE
Lyophilized: Store at –20°C, protect from light and moisture.
Reconstituted: Store at 2–8°C, avoid freeze–thaw cycles.
RESEARCH USE ONLY
This product is supplied strictly for laboratory, research, and development use. Not for human consumption or therapeutic application.